CAREDX INC. - COMMON STOCK

CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes

18 11 2021 06:00:00 提供 Nasdaq GlobeNewswire

CareDx To Participate in Upcoming Conferences

15 11 2021 15:05:00 提供 Nasdaq GlobeNewswire

CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence

10 11 2021 06:00:03 提供 Nasdaq GlobeNewswire

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices

04 11 2021 06:00:01 提供 Nasdaq GlobeNewswire

CareDx Focuses on Innovation in Transplant at ASN Kidney Week

03 11 2021 06:00:02 提供 Nasdaq GlobeNewswire

CareDx Completes Orderly Management Transition

01 11 2021 15:01:00 提供 Nasdaq GlobeNewswire

CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance

28 10 2021 15:01:00 提供 Nasdaq GlobeNewswire

CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study

21 10 2021 06:00:01 提供 Nasdaq GlobeNewswire

CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

19 10 2021 06:00:01 提供 Nasdaq GlobeNewswire

CareDx to Report Third Quarter 2021 Financial Results

14 10 2021 15:01:00 提供 Nasdaq GlobeNewswire

AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients

12 10 2021 09:18:53 提供 Nasdaq GlobeNewswire

CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication

30 9 2021 15:01:00 提供 Nasdaq GlobeNewswire

CareDx Continues to Fight for Innovation in Transplantation

28 9 2021 18:18:01 提供 Nasdaq GlobeNewswire

CareDx Presents Latest Data on AlloSeq Portfolio at ASHI 2021

27 9 2021 06:00:00 提供 Nasdaq GlobeNewswire

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

15 9 2021 07:00:00 提供 Nasdaq GlobeNewswire

CareDx to Participate in Upcoming Conferences

02 9 2021 06:00:01 提供 Nasdaq GlobeNewswire

CareDx Showcases Leadership in Global Transplantation at ESOT 2021

26 8 2021 06:00:01 提供 Nasdaq GlobeNewswire

CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance

29 7 2021 15:01:00 提供 Nasdaq GlobeNewswire

CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients

26 7 2021 06:00:00 提供 Nasdaq GlobeNewswire

CareDx to Report Second Quarter 2021 Financial Results

15 7 2021 06:00:00 提供 Nasdaq GlobeNewswire